Session Details

[28-11-am]Evaluation of drug efficacy and safety, Chemotherapeutic agents, Kampo medicines, Others

Fri. Mar 28, 2025 8:30 AM - 10:06 AM JST
Fri. Mar 28, 2025 11:30 PM - 1:06 AM UTC
Room 11 (Fukuoka International Congress Center: 413 [4F])
Chair: Ichiro Horie, Kenji Sakamoto

[28-11-am01S]Discovery of a sesquiterpenoid as the novel insulinotropic compound

○Moena Goto1, Kazunori Hashimoto1, Tomiyasu Murata1 (1. Fac.Pharm.,Meijo Univ.)

[28-11-am02S]The relationship between intestinal microbiota and intestinal barrier that regulate responders and non-responders to action of Daiokanzoto

○Hana Hyogo1, Yuki Tachigami1, Chiho Takahara1, Masanori Iseki2, Ryoko Tomita3, Tadashi Hayama3, Katsuhiko Ishihara4, Hirofumi Inoue1, Takashi Tanaka5, Gen-ichiro Nonaka6, Kento Takayama1,2 (1. Pharm. Sci., Fukuyama Univ., 2. Kawasaki Medical School, 3. Pharm. Sci., Fukuoka Univ., 4. Kawasaki University of Medical Welfare, 5. Institute of Biomedical Sciences, Nagasaki Univ., 6. Usaien Pharmaceutical Co., Ltd.)

[28-11-am03]Functional changes in variant enzymes derived from CYP2C19 genetic polymorphisms in Japanese individuals

○Eiji Hishinuma1,2, Akiko Ueda1, Yuma Suzuki3, Tomoki Nakayoshi4, Akifumi Oda4, Sakae Saito1,2, Shu Takada2, Kengo Kinoshita1,2,5, Masahiro Hiratsuka1,2,3,6 (1. INGEM, Tohoku Univ., 2. ToMMo, Tohoku Univ., 3. Grad. Sch. Pharm. Sci., Tohoku Univ., 4. Fac. Pharm. Sci., Meijo Univ., 5. Grad. Sch. of Inf. Sci., Tohoku Univ., 6. Depart. Pharm. Sci., Tohoku Univ. Hosp.)

[28-11-am04S]Effects of aging on changes in pupil size associated with dark adaptation

○Taiga Hasegawa1, Yohei Yamashita1, Yoshinori Iba1 (1. Science and Engineering, Setsunan University)

[28-11-am05S]Development of water-soluble resveratrol micelle formulation using polyethylene glycol monostearate and evaluation of its neuroprotective effect on hemorrhagic brain injury

○Aoi Machida1, Saki Kawamura2, Riko Okada2, Yui Kawamoto2, Tetsuhiro Yamada2, Yoshiharu Kaneo1,2, Tetsuro Tanaka1,2, Kengo Banshoya1,2, Masatoshi Ohnishi1,2 (1. Grad. Sch. Pharm. Sci., Fukuyama Univ., 2. Fac. Pharm. Sci., Fukuyama Univ.)

[28-11-am06S]Inhibitory effect of Ninjinyoeito against myeloid-derived suppressor cells in aging-model mice

○Mai Morinaga1, Haruna Adachi1, Hironori Kawakami1, Hisaaki Shinohara1, Akira Shimamoto1, Takahiko Shimizu2, Seiwa Michihara3, Shigeki Chiba3, Ryuji Takahashi3, Yoichiro Isohama4, Ichiro Horie1 (1. Fac. Pharm. Sci., Sanyo-Onoda City Univ., 2. Natl. Ctr. Geriatr. Gerontol., 3. Kampo Res. Lab., Pharm. Co., Kracie, Ltd.Kampo Res. Lab., Pharm. Co., Kracie, Ltd., 4. Grad. Sch. Pharm. Sci., Tokyo Univ. of Sci.)

[28-11-am07]In vitro assessment of drug-induced liver injury using 3D-cultured hepatocytes derived from chimeric mice with humanized liver

○Hiroyuki Kawagishi1, Xingming Liu1, Yuta Sakamoto1, Yuichiro Higuchi2, Shotaro Uehara2, Hiroshi Suemizu2, Yasunari Kanda1 (1. Natl. Inst. Health Sci., 2. Cntr. Inst. for Exp. Med. and Life Sci.)

[28-11-am08]AI-based modeling of molecular network activities in coronavirus pathway and epithelial-mesenchymal transition pathway

○Shihori Tanabe1, Sabina Quader2, Ryuichi Ono1, Horacio Cabral3, Ed Perkins4, Hiroki Sasaki5 (1. Natl. Inst. Health Sci., 2. iCONM, 3. Fac. Engineer., Univ. Tokyo, 4. US Army Engineer R&D Ctr, USA, 5. Natl. Cancer Ctr. Res. Inst.)